日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score(®) test among node-negative early breast cancer patients in Japan

日本淋巴结阴性早期乳腺癌患者中Oncotype DX乳腺复发评分(®)检测的成本效益分析

Koizumi, Kei; Igarashi, Ataru; Gouldson, Mark; Bilthare, Sandeep; Eymere, Sebastien; Cuyún-Carter, Gebra; Millen, Steve; Nomoto, Mariko; Onishi, Yoshie; Kudo, Aki; Drost, Pieter; Sugiyama, Naoko; Tang, Tom Kanazawa; Niikura, Naoki

Microsimulation model to identify suboptimal recurrence detection in patients with colorectal cancer following the current standard of care

利用微观模拟模型识别当前标准治疗方案下结直肠癌患者复发检测的不足之处

Samur, Sumeyye; Gursel, Emir; Gu, Ning Yan; Carter, Gebra Cuyun; Sahinkoc, Mert; Ayer, Turgay; Chhatwal, Jagpreet; Subramaniam, Somasundaram; Palomares, Melanie; Parikh, Aparna R; Neugut, Alfred I

Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung Cancer

晚期非小细胞肺癌患者全外显子组、全转录组测序的成本和效益

Ortendahl, Jesse D; Cuyun Carter, Gebra; Thakkar, Snehal G; Bognar, Katalin; Hall, David W; Abdou, Yara; Gandara, David

Cost-Utility Analysis of Multigene Assays to Guide Treatment Decisions for Node-Negative Early Breast Cancer

多基因检测指导淋巴结阴性早期乳腺癌治疗决策的成本效用分析

Berdunov, Vladislav; Cuyún-Carter, Gebra; Gil-Rojas, Yaneth; Russell, Christy; Campbell, Sara; Racz, Jennifer; Abdou, Yara

Assigning cancer stage to patients using administrative claims data: an example for colon and rectal cancers

利用行政索赔数据确定癌症分期:以结肠癌和直肠癌为例

Smith, Rebecca A; Cao, Xiting; Cuyun Carter, Gebra; Fayyaz, Ifrah; Pope, Andreyah; Ellenberg, Phil; Miller-Wilson, Lesley-Ann; Limburg, Paul J; Pyenson, Bruce

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care

关于公平、广泛地在癌症护理中实施液体活检的建议

Febbo, Phillip G; Allo, Mina; Alme, Emma B; Cuyun Carter, Gebra; Dumanois, Robert; Essig, Alessia; Kiernan, Estevan; Kubler, Caitlin B; Martin, Nikki; Popescu, Medeea C; Leiman, Lauren C

Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score(®) Test from a US Societal Perspective

从美国社会角度对Oncotype DX乳腺癌复发评分(®)检测进行成本效益分析

Berdunov, Vladislav; Cuyun Carter, Gebra; Laws, Ewan; Luo, Roger; Russell, Christy A; Campbell, Sara; Abdou, Yara; Force, Jeremy

Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer

下一代测序检测在晚期癌症管理中的临床影响的综合评价

Gibbs, Sarah N; Peneva, Desi; Cuyun Carter, Gebra; Palomares, Melanie R; Thakkar, Snehal; Hall, David W; Dalglish, Hannah; Campos, Cynthia; Yermilov, Irina

Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration

利用数据整合改善美国非小细胞肺癌真实世界健康结果研究:描述性和定性探索

Grabner, Michael; Molife, Cliff; Wang, Liya; Winfree, Katherine B; Cui, Zhanglin Lin; Cuyun Carter, Gebra; Hess, Lisa M

Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer: A Systematic Literature Review

激素受体阳性/人表皮生长因子受体2阴性(HR+/HER2-)晚期乳腺癌的预后因素:系统性文献综述

Cuyún Carter, Gebra; Mohanty, Maitreyee; Stenger, Keri; Morato Guimaraes, Claudia; Singuru, Shivaprasad; Basa, Pradeep; Singh, Sheena; Tongbram, Vanita; Kuemmel, Sherko; Guarneri, Valentina; Tolaney, Sara M